Subsidy Tracker Parent Company Summary

Parent Company Name: 
GlaxoSmithKline
Ownership Structure: 
publicly traded (ticker symbol GSK)
Headquartered in: 
Britain
Major Industry: 
pharmaceuticals
Specific Industry: 
pharmaceuticals
Subsidy SummarySubsidy ValueNumber of Awards
State/Local$60,230,17034
Federal (grants and allocated tax credits)$6,935,5436
TOTAL$67,165,71340
Loan / Bailout SummaryTotal Face ValueNumber of Awards
State/Local loans, bond financing and venture capital$00
Federal loans, loan guarantees and bailout assistance (not including repayments)$00
TOTAL$00
Time Period for State and Local Awards: 

Earliest year of data: 2000. Availability of data for earlier years varies greatly from program to program. The majority of the listings for this parent company are for the period since 2012.

Time Period for Federal Awards: 

FY2000 to the present

Notes: 

Dollar totals do not include awards for which no subsidy value is disclosed.

Associated Names: 

GLAXOSMITHKLINE; GLAXOWELLCOME; SMITHKLINE BEECHAM; SMITHKLINE BEECHAM DBA GLAXOSMITHKLINE

Links: 

For a summary of this company's regulatory violations see its Violation Tracker summary page here.

For an overview of this company's accountability track record, read its Corporate Rap Sheet here.

For more details on misconduct by this company, see its entry in the Project On Government Oversight's Federal Contractor Misconduct Database.

For a summary of this company's federal contracts, see its page on Fedspending.

For an overview of political contributions associated with this company, see its Follow the Money page.


Top 5 States for state/local awardsTotal Subsidy $Number of Awards
North Carolina$35,763,17810
Pennsylvania$19,821,79111
New York$3,464,0487
Washington$935,6324
Montana$240,0001
All other$5,5211

Individual Subsidy Records:

Click on the company name for more information on each subsidy award.
Download results as CSV or XML
Company Location Subsidy Source Year Subsidy Valuesort icon Loan/Bailout Value Type of Subsidy
GlaxoSmithkline Holdings Americas , Inc. North Carolina state 2015 $8,524,608 tax credit/rebate
GlaxoSmithkline Holdings Americas , Inc. North Carolina state 2013 $4,414,142 tax credit/rebate
GlaxoSmithkline Holdings Americas , Inc. North Carolina state 2013 $4,414,142 tax credit/rebate
GlaxoSmithKline, LLC ( f/k/a SmithKline Beecham Corporation) Pennsylvania state 2012 $4,247,696 tax credit/rebate
GlaxoSmithkline Holdings Americas , Inc. North Carolina state 2016 $4,121,650 tax credit/rebate
GlaxoSmithkline Holdings Americas , Inc. North Carolina state 2011 $4,039,279 tax credit/rebate
GlaxoSmithKline Holdings Americas , Inc. North Carolina state 2012 $4,025,543 tax credit/rebate
GlaxoSmithKline Holdings Americas , Inc. North Carolina state 2012 $4,025,543 tax credit/rebate
GlaxoSmithKline United States federal 2012 $4,011,709 federal grant
GlaxoSmithKline, LLC (f/k/a SmithKline Beecham Corporation) Pennsylvania state 2014 $3,353,317 tax credit/rebate
SmithKline Beecham Corporation DBA GlaxoSmithKline Pennsylvania state 2008 $2,990,917 tax credit/rebate
GlaxoSmithKline, LLC ( f/k/a SmithKline Beecham Corporation) Pennsylvania state 2013 $2,357,066 tax credit/rebate
GlaxoSmithKline, LLC (f/k/a SmithKline Beecham Corporation) Pennsylvania state 2015 $2,269,398 tax credit/rebate
GlaxoSmithKline Beecham Corp North Carolina state 2005 $1,859,000 grant
GlaxoSmithKline Biologicals North America dba Corixa Pennsylvania state $1,350,000 tax credit/rebate
GlaxoSmithKline Biologicals North America dba Corixa Pennsylvania state $1,350,000 grant
SmithKline Beecham Corporation DBA GlaxoSmithKline Pennsylvania state 2011 $951,581 tax credit/rebate
GlaxoSmithKline United States federal 2012 $729,692 federal grant
SMITHKLINE BEECHAM RESEARCH CO United States federal 2006 $620,077 federal grant
GLAXOSMITHKLINE, INC United States federal 2001 $606,644 federal grant
SMITHKLINE BEECHAM RESEARCH CO United States federal 2006 $592,421 federal grant
GLAXOSMITHKLINE & Stiefel Laboratories Inc. New York local 2017 $540,625 tax credit/rebate
GLAXOSMITHKLINE & Stiefel Laboratories Inc. New York local 2015 $534,097 tax credit/rebate
GLAXOSMITHKLINE & Stiefel Laboratories Inc. New York local 2016 $534,097 tax credit/rebate
GLAXOSMITHKLINE & Stiefel Laboratories Inc. New York local 2011 $488,081 tax credit/rebate; property tax abatement
GLAXOSMITHKLINE & Stiefel Laboratories Inc. New York local 2013 $470,487 tax credit/rebate; property tax abatement
GLAXOSMITHKLINE & Stiefel Laboratories Inc. New York local 2012 $464,160 tax credit/rebate; property tax abatement
SmithKline Beecham Corporation DBA GlaxoSmithKline Pennsylvania state 2010 $435,635 tax credit/rebate
GLAXOSMITHKLINE & Stiefel Laboratories Inc. New York local 2014 $432,501 tax credit/rebate
GLAXOSMITHKLINE BIOLOGICALS NORTH AMERICA Washington state 2006 $397,686 tax credit/rebate
SMITHKLINE BEECHAM CORPORATION United States federal 2000 $375,000 federal grant
GlaxoSmithKline Biologicals North America Pennsylvania state $316,181 training reimbursement
GLAXOSMITHKLINE BIOLOGICALS NORTH AMERICA Washington state 2004 $253,000 tax credit/rebate
GlaxoSmithKline Biologicals Montana state 2011 $240,000 grant/loan hybrid program
GlaxoSmithKline Pennsylvania state $200,000 training reimbursement
GlaxoSmithkline Holdings Americas, Inc. North Carolina state 2015 $171,518 tax credit/rebate
GLAXOSMITHKLINE BIOLOGICALS NORTH AMERICA Washington state 2004 $168,442 tax credit/rebate
GlaxoSmithkline Holdings Americas , Inc. North Carolina state 2013 $167,753 tax credit/rebate
GLAXOSMITHKLINE BIOLOGICALS NORTH AMERICA Washington state 2007 $116,504 tax credit/rebate
GLAXOWELLCOME INC Tennessee local 2008 $5,521 property tax abatement
Download results as CSV or XML